Drugs for Coagulation Disorders Flashcards

1
Q

what is hemostasis?

A
  • vessel spasms, constricting the vessel and limiting blood flow to the site of injury
  • platelets bind with high affinity to the damaged vessel; activated platelets release ADP and thromboxane A2 which stimulate the activation of new platelets, platelet aggregation and vasoconstriction
  • thrombin is produced, thrombin will convert fibrinogen into fibrin, fibrin provides the scaffolding that forms a clot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when is the extrinsic pathway activated?

A
  • triggered when tissue thromboplastin is released from damaged cells (outside the circulation)
  • catalyzes for formation of factor Xa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when is the intrinsic pathway activated?

A
  • triggered when collagen is exposed at the site of vascular injury to blood components (inside the circulation)
  • catalyzes formation of factor Xa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when is the common pathway activated?

A
  • synthesis of factor Xa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TPA

A
  • cells adjacent to the clot release tissue plasminogen activator
  • converts plasminogen into plasmin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the mechanism of action of plasmin?

A
  • plasmin digests fibrin and destroys the clot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when is fibrinolysis initiated?

A
  • 24 to 48 hours after clot formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is included with thromboembolic disorders?

A
  • formation of non-therapeutic clots
  • occlusion of arterial vessels lead to MI and stroke
  • embolus; piece of stable thrombi breaks off and lodges in smaller blood vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is included in bleeding disorders?

A
  • thrombocytopenia (bone marrow suppression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the most commonly prescribed coagulation modifiers?

A
  • anticoagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what drug class would be given to inhibit specific clotting factors?

A
  • anticoagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what drug class would be given to inhibit platelet actions?

A
  • anticoagulants

- antiplatelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what drug class would be given to dissolve a clot?

A
  • thrombolytics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what drug class would be given to inhibit the destruction of fibrin?

A
  • antifibrinolytics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the mechanism of action of anticoagulant drugs?

A
  • modulate coagulation cascade and thrombin formation

- lengthen clotting times and prevent thrombi from forming in veins and arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

in cases of MI or stroke, how would anticoagulants be administered? give an example

A
  • IV or SC for rapid onset of action (ex. heparin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the 5 anticoagulant drugs?

A
  • heparin
  • warfarin
  • low molecular weight heparins
  • direct thrombin inhibitors
  • direct acting factor Xa inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how is heparin administered?

A
  • IV or SC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

where is heparin made?

A

-found in liver and lining of blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is heparin’s antidote?

A
  • protamine sulphate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how is warfarin administered?

A
  • PO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is warfarin’s antidote?

A
  • vitamin K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is a low molecular weight heparin antidote?

A
  • protamine sulphate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the mechanism of action of heparin?

A
  • catalyzes the inactivation of thrombin
  • enhances the ability of antithrombin III to inactivate thrombin and clotting factors
  • thrombin no longer available to convert fibrinogen into fibrin
  • inhibition of factor Xa, inhibits intrinsic and extrinsic pathways of the clotting cascade
25
what is heparin prescribed for?
- used for prevention of venous thrombosis, pulmonary embolism, disseminated intravascular coagulation, treatment in MI and stroke
26
what is it important to monitor for with heparin?
- bleeding
27
what is the mechanism of action of low molecular weight heparins?
- same mechanism of action as heparin, but more specific to factor Xa - produces a more stable response than unfractioned heparin since thrombin remains active
28
what are some benefits of low molecular weight heparin?
- reduced risk for thrombocytopenia - longer duration of action, reduced dosing frequency - drug class of choice for the prevention of DVT
29
what is the mechanism of action of warfarin?
- blocks synthesis of clotting factors thrombin, VIIa, IXa and Xa - precursors require carboxylation to become active - carboxylation linked to oxidation of vitamin K to vitamin K epoxide - inhibits vitamin K epoxide reductase
30
what is vitamin K essential for?
- clotting
31
how is vitamin K epoxide recycled to its reduced form?
- vitamin K epoxide is not used in the body | - vitamin k epoxide reductase recycles it back to vitamin K
32
what do you closely monitor for when patient is on both heparin and warfarin?
- spontaneous bleeding
33
what should patients avoid when taking warfarin?
- avoid vitamin-K rich foods because it reduces the effectiveness of the drug - strenuous activities that could result in an injury
34
what is the mechanism of action for direct acting thrombin inhibitors?
- prevents conversion of fibrinogen to fibrin, inhibiting clot formation
35
direct acting thrombin inhibitors are used to reduce the risk of what?
- stroke, systemic embolism in clients with A fib, DVT, pulmonary embolism
36
what circumstance are direct acting thrombin inhibitors used as an alternative therapy?
- heparin induced thrombocytopenia
37
when would praxbind (direct acting thrombin inhibitor antagonist) be used?
- life threatening bleeding or uncontrolled bleeding | - emergency surgeries
38
what is the mechanism of action of the direct acting factor Xa inhibitors?
- inhibits intrinsic and extrinsic pathways of the coagulation cascade - reduces thrombin formation and development of thrombi; no direct effects on thrombin or platelets
39
direct acting factor Xa inhibitors are used to to prevent/ treat what?
- deep vein thrombosis | - reduces the risk of pulmonary emboli in patients undergoing knee or hip replacements
40
what caution precautions should be taken with anticoagulant drugs?
-patients with hemorrhagic disorders, recent trauma, spinal puncture, GI ulcers, recent surgery
41
what is warfarin contraindicated with?
- pregnancy and during lactation
42
what are some common adverse effects with anticoagulant drugs?
- bleeding - international normalized ratio (measures prothrombin levels) - prothrombin time (time required for clotting to occur)
43
what are the three drug classes for anti platelet drugs?
- irreversible cyclooxygenase inhibitors - adenosine diphosphate receptor antagonists - glycoprotein IIb and IIIa receptor antagonists
44
what is the mechanism of action of irreversible cyclooxygenase inhibitors (ASPARIN)?
- irreversibly blocks the activity of COX 1 and COX 2 enzymes - inhibits the synthesis of prostaglandins and thromboxane A2
45
what are the benefits of irreversible cyclooxygenase inhibitors?
- patients with established cardiovascular disease
46
what is the mechanism of action for an ADP receptor antagonist?
- irreversibly change the molecular conformation of ADP receptors present on platelets - platelets no longer receive chemical signal to aggregate, thereby inhibiting thrombus formation
47
- what is the mechanism of action of glycoprotein IIb and IIIa receptor antagonists?
- glycoprotein IIb and IIIa enzymes are involved in platelet aggregation - antagonist activity at receptors prevents platelet aggregation and thrombus formation
48
how are glycoproteins administered?
- IV route
49
what are caution precautions with antiplatelet drugs?
- presence of any known bleeding disorders - recent surgery - closed head injuries
50
what is the mechanism of action for thrombolytics drugs?
- promote fibrinolysis by converting plasminogen to plasmin | - dissolve insoluble fibrin with intravascular emboli and thrombi
51
when are thrombolytics drugs administered?
- to dissolve pre-existing clots | - MI, pulmonary embolism, ischemic CVS, DVT
52
what is the mechanism of action of streptokinase?
- enzyme made by bacteria - can cause an immunological reaction - may result in systemic fibrinolysis
53
what is the mechanism of action of the tissue plasminogen activators?
- identical to human TPA - converts plasminogen to plasmin, which dissolves clots - specific to fibrin bound plasminogen
54
what is contraindicated with thrombolytic drugs?
- recent trauma or bleeding disorders
55
what do you monitor for with thrombolytic drugs?
- cerebral hemorrhage
56
what is the antidote for thrombolytic drugs?
- aminocaproic acid
57
what is the mechanism of action for an antifibrinolytic drug and when is it used?
- used to facilitate blood clotting and shorten bleeding time - post surgery to reduce bleeding at surgical sites
58
what does aminocaproic acid do?
- an enzyme inhibitor that inactivates plasmin